J. A. P. van der Sloot

The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience*

Annemarie E. Engström, Ricardo Cocchieri, Antoine H.G. Driessen et al. · Critical Care Medicine · 2011 · 126 citations

LDL‐C/HDL‐C ratio in subjects with cardiovascular disease and a low HDL‐C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study

J. Wouter Jukema, Anho Liem, Peter H.J.M. Dunselman et al. · Current Medical Research and Opinion · 2005 · 60 citations

Transmyocardial revascularization using an XeCl excimer laser: Results of a randomized trial

J. A. P. van der Sloot, Menno Huikeshoven, Raymond Tukkie et al. · The Annals of Thoracic Surgery · 2004 · 36 citations · Full text

Engineering, Transmyocardial Revascularization, Xecl Excimer Laser +6

Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.

Annemarie E. Engström, Hans Granfeldt, W. Seybold-Epting et al. · PubMed · 2013 · 33 citations

Cardiac denervation after clinical transmyocardial laser revascularization: short-term and long-term iodine 123–labeled meta-iodobenzylguanide scintigraphic evidence

Johan F. Beek, J. A. P. van der Sloot, Menno Huikeshoven et al. · Journal of Thoracic and Cardiovascular Surgery · 2004 · 20 citations · Full text

Cardiac Denervation, Cardiac Muscle, Cardiomyopathy +8